PeopleBio, Inc. (KOSDAQ:304840)

South Korea · Delayed Price · Currency is KRW

561.00

-9.00 (-1.58%)

At close: Jul 31, 2026

PeopleBio Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,837	2,851	2,531	4,453	4,445	577.08
Revenue Growth	119.84%	12.64%	-43.17%	0.18%	670.22%	13.63%
Gross Profit	702.53	-476.51	430.9	1,376	1,330	-787.66
Operating Income	-10,771	-12,197	-8,685	-15,248	-11,697	-7,236
Net Income	-15,722	-15,714	-10,913	-16,035	-14,303	-4,697
Earnings Per Share	-696.76	-722.13	-502.00	-967.45	-978.00	-457.08
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	301.83	80.1	6,393	5,244	22,664	38,930
Total Debt	76,491	7,756	9,252	2,554	16,352	13,748
Net Cash (Debt)	-76,189	-7,676	-2,859	2,690	6,312	25,182
Net Cash Growth	-	-	-	-57.39%	-74.94%	175.24%
Net Cash Per Share	-3372.81	-352.75	-131.50	162.28	431.46	1569.96

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-4,982	-5,183	-10,911	-16,282	-13,975	-6,833
Capital Expenditures	-4,948	-213.61	-78.6	-719.15	-1,267	-1,355
Free Cash Flow	-9,930	-5,396	-10,990	-17,001	-15,242	-8,188
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	18.31%	-16.72%	17.03%	30.90%	29.92%	-136.49%
Operating Margin	-280.71%	-427.87%	-343.21%	-342.42%	-263.16%	-1253.81%
Pretax Margin	-330.04%	-440.11%	-362.12%	-390.36%	-337.53%	-856.37%
Profit Margin	-409.75%	-551.26%	-431.25%	-360.10%	-321.79%	-813.94%
FCF Margin	-258.81%	-189.30%	-434.27%	-381.80%	-342.91%	-1418.84%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	299.64	299.64	299.64	299.64	299.64
PS Ratio	3.55	7.94	25.51	14.52	41.73	316.73